New Study: Rapid Antigen Tests Compare Well With Quarantine in Halting Travel-Imported COVID Cases 25/03/2021 Raisa Santos A new study published by a consortium of UK-based airline industry interests suggested that administration to travelers of a rapid antigen test upon arrival at their destination, may be just as effective as quarantine requirements, to stop imports of COVID-19 cases. The study, which reviewed case studies of airport testing procedures elsewhere, claims that a […] Continue reading -> Africa Warns Against COVID-19 Vaccine Wars: Pleads For Fair Distribution 25/03/2021 Paul Adepoju About 10 African countries have yet to receive any doses of a COVID vaccine, while at least one country, Rwanda, has already run out of the doses that it received through the WHO co-sponsored COVAX facility, said WHO’s African Regional Office on Thursday, citing this as evidence of the vaccine inequalities that continue to […] Continue reading -> India Investigates New SARS-CoV2 ‘Double Variant’ – Bearing Two Significant Spike Protein Mutations 25/03/2021 Menaka Rao NEW DELHI – Scientists have sequenced a new “double variant” of the coronavirus first identified in India – along with a handful of other variants of concern that are appearing during the second biggest wave of the virus since the pandemic began. The new double variant, bearing two significant mutations in the coronavirus spike protein, […] Continue reading -> New Oral MDR-TB Treatment Shows Positive Trial Results – Potential To Change Clinical Practice & Save Lives 24/03/2021 Chandre Prince A first-ever clinical trial of a new, all-oral, treatment regime for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients after initial data provided positive results that the new treatment could potentially save thousands of lives, as well as improving peoples’ quality of life. Findings of the TB-PRACTECAL, Phase II/III clinical trial sponsored by Médecins Sans Frontières […] Continue reading -> Many South African Children Don’t Get TB Treatment Due to Diagnostic and Reporting Challenges 24/03/2021 Editorial team A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading -> Decolonizing Tuberculosis Care: A Perspective From The Global South On World TB Day 24/03/2021 Uzma Khan Tuberculosis care is quintessentially colonial, even in 2021. While many countries have been emancipated from their colonizers, the heritage of the colonial mindset, culture and even entire economies is deeply embedded within high burden TB countries in the post-colonial era. A disease of poverty, TB has historically been terribly neglected. Although the number one infectious […] Continue reading -> Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> New TB Screening Tools Combine X-Rays & AI 23/03/2021 Menaka Rao NEW DELHI – Reversing decades of negative messages, the World Health Organisation is once again endorsing the use of X-rays as a TB screening tool in lower-income countries – this time in conjunction with the use of new artificial intelligence programmes that can read digital x-rays and identify suspected TB cases more accurately. For community-level […] Continue reading -> Norway Gives Up COVAX Doses Despite Domestic Pressure – ACT Accelerator proposes manufacturing task force 23/03/2021 Kerry Cullinan In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa Warns Against COVID-19 Vaccine Wars: Pleads For Fair Distribution 25/03/2021 Paul Adepoju About 10 African countries have yet to receive any doses of a COVID vaccine, while at least one country, Rwanda, has already run out of the doses that it received through the WHO co-sponsored COVAX facility, said WHO’s African Regional Office on Thursday, citing this as evidence of the vaccine inequalities that continue to […] Continue reading -> India Investigates New SARS-CoV2 ‘Double Variant’ – Bearing Two Significant Spike Protein Mutations 25/03/2021 Menaka Rao NEW DELHI – Scientists have sequenced a new “double variant” of the coronavirus first identified in India – along with a handful of other variants of concern that are appearing during the second biggest wave of the virus since the pandemic began. The new double variant, bearing two significant mutations in the coronavirus spike protein, […] Continue reading -> New Oral MDR-TB Treatment Shows Positive Trial Results – Potential To Change Clinical Practice & Save Lives 24/03/2021 Chandre Prince A first-ever clinical trial of a new, all-oral, treatment regime for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients after initial data provided positive results that the new treatment could potentially save thousands of lives, as well as improving peoples’ quality of life. Findings of the TB-PRACTECAL, Phase II/III clinical trial sponsored by Médecins Sans Frontières […] Continue reading -> Many South African Children Don’t Get TB Treatment Due to Diagnostic and Reporting Challenges 24/03/2021 Editorial team A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading -> Decolonizing Tuberculosis Care: A Perspective From The Global South On World TB Day 24/03/2021 Uzma Khan Tuberculosis care is quintessentially colonial, even in 2021. While many countries have been emancipated from their colonizers, the heritage of the colonial mindset, culture and even entire economies is deeply embedded within high burden TB countries in the post-colonial era. A disease of poverty, TB has historically been terribly neglected. Although the number one infectious […] Continue reading -> Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> New TB Screening Tools Combine X-Rays & AI 23/03/2021 Menaka Rao NEW DELHI – Reversing decades of negative messages, the World Health Organisation is once again endorsing the use of X-rays as a TB screening tool in lower-income countries – this time in conjunction with the use of new artificial intelligence programmes that can read digital x-rays and identify suspected TB cases more accurately. For community-level […] Continue reading -> Norway Gives Up COVAX Doses Despite Domestic Pressure – ACT Accelerator proposes manufacturing task force 23/03/2021 Kerry Cullinan In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
India Investigates New SARS-CoV2 ‘Double Variant’ – Bearing Two Significant Spike Protein Mutations 25/03/2021 Menaka Rao NEW DELHI – Scientists have sequenced a new “double variant” of the coronavirus first identified in India – along with a handful of other variants of concern that are appearing during the second biggest wave of the virus since the pandemic began. The new double variant, bearing two significant mutations in the coronavirus spike protein, […] Continue reading -> New Oral MDR-TB Treatment Shows Positive Trial Results – Potential To Change Clinical Practice & Save Lives 24/03/2021 Chandre Prince A first-ever clinical trial of a new, all-oral, treatment regime for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients after initial data provided positive results that the new treatment could potentially save thousands of lives, as well as improving peoples’ quality of life. Findings of the TB-PRACTECAL, Phase II/III clinical trial sponsored by Médecins Sans Frontières […] Continue reading -> Many South African Children Don’t Get TB Treatment Due to Diagnostic and Reporting Challenges 24/03/2021 Editorial team A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading -> Decolonizing Tuberculosis Care: A Perspective From The Global South On World TB Day 24/03/2021 Uzma Khan Tuberculosis care is quintessentially colonial, even in 2021. While many countries have been emancipated from their colonizers, the heritage of the colonial mindset, culture and even entire economies is deeply embedded within high burden TB countries in the post-colonial era. A disease of poverty, TB has historically been terribly neglected. Although the number one infectious […] Continue reading -> Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> New TB Screening Tools Combine X-Rays & AI 23/03/2021 Menaka Rao NEW DELHI – Reversing decades of negative messages, the World Health Organisation is once again endorsing the use of X-rays as a TB screening tool in lower-income countries – this time in conjunction with the use of new artificial intelligence programmes that can read digital x-rays and identify suspected TB cases more accurately. For community-level […] Continue reading -> Norway Gives Up COVAX Doses Despite Domestic Pressure – ACT Accelerator proposes manufacturing task force 23/03/2021 Kerry Cullinan In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Oral MDR-TB Treatment Shows Positive Trial Results – Potential To Change Clinical Practice & Save Lives 24/03/2021 Chandre Prince A first-ever clinical trial of a new, all-oral, treatment regime for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients after initial data provided positive results that the new treatment could potentially save thousands of lives, as well as improving peoples’ quality of life. Findings of the TB-PRACTECAL, Phase II/III clinical trial sponsored by Médecins Sans Frontières […] Continue reading -> Many South African Children Don’t Get TB Treatment Due to Diagnostic and Reporting Challenges 24/03/2021 Editorial team A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading -> Decolonizing Tuberculosis Care: A Perspective From The Global South On World TB Day 24/03/2021 Uzma Khan Tuberculosis care is quintessentially colonial, even in 2021. While many countries have been emancipated from their colonizers, the heritage of the colonial mindset, culture and even entire economies is deeply embedded within high burden TB countries in the post-colonial era. A disease of poverty, TB has historically been terribly neglected. Although the number one infectious […] Continue reading -> Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> New TB Screening Tools Combine X-Rays & AI 23/03/2021 Menaka Rao NEW DELHI – Reversing decades of negative messages, the World Health Organisation is once again endorsing the use of X-rays as a TB screening tool in lower-income countries – this time in conjunction with the use of new artificial intelligence programmes that can read digital x-rays and identify suspected TB cases more accurately. For community-level […] Continue reading -> Norway Gives Up COVAX Doses Despite Domestic Pressure – ACT Accelerator proposes manufacturing task force 23/03/2021 Kerry Cullinan In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Many South African Children Don’t Get TB Treatment Due to Diagnostic and Reporting Challenges 24/03/2021 Editorial team A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading -> Decolonizing Tuberculosis Care: A Perspective From The Global South On World TB Day 24/03/2021 Uzma Khan Tuberculosis care is quintessentially colonial, even in 2021. While many countries have been emancipated from their colonizers, the heritage of the colonial mindset, culture and even entire economies is deeply embedded within high burden TB countries in the post-colonial era. A disease of poverty, TB has historically been terribly neglected. Although the number one infectious […] Continue reading -> Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> New TB Screening Tools Combine X-Rays & AI 23/03/2021 Menaka Rao NEW DELHI – Reversing decades of negative messages, the World Health Organisation is once again endorsing the use of X-rays as a TB screening tool in lower-income countries – this time in conjunction with the use of new artificial intelligence programmes that can read digital x-rays and identify suspected TB cases more accurately. For community-level […] Continue reading -> Norway Gives Up COVAX Doses Despite Domestic Pressure – ACT Accelerator proposes manufacturing task force 23/03/2021 Kerry Cullinan In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Decolonizing Tuberculosis Care: A Perspective From The Global South On World TB Day 24/03/2021 Uzma Khan Tuberculosis care is quintessentially colonial, even in 2021. While many countries have been emancipated from their colonizers, the heritage of the colonial mindset, culture and even entire economies is deeply embedded within high burden TB countries in the post-colonial era. A disease of poverty, TB has historically been terribly neglected. Although the number one infectious […] Continue reading -> Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> New TB Screening Tools Combine X-Rays & AI 23/03/2021 Menaka Rao NEW DELHI – Reversing decades of negative messages, the World Health Organisation is once again endorsing the use of X-rays as a TB screening tool in lower-income countries – this time in conjunction with the use of new artificial intelligence programmes that can read digital x-rays and identify suspected TB cases more accurately. For community-level […] Continue reading -> Norway Gives Up COVAX Doses Despite Domestic Pressure – ACT Accelerator proposes manufacturing task force 23/03/2021 Kerry Cullinan In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Wellcome Trust Pledges Further US $100 million to Accelerate Covid-19 Research 24/03/2021 Editorial team The Wellcome trust is pledging up to US $100 million (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus. The funding will help advance treatments and vaccines and SARS-CoV-2 tracking research in low and middle income countries. Announcing the funding on Wednesday, the trust said the rise and spread […] Continue reading -> New TB Screening Tools Combine X-Rays & AI 23/03/2021 Menaka Rao NEW DELHI – Reversing decades of negative messages, the World Health Organisation is once again endorsing the use of X-rays as a TB screening tool in lower-income countries – this time in conjunction with the use of new artificial intelligence programmes that can read digital x-rays and identify suspected TB cases more accurately. For community-level […] Continue reading -> Norway Gives Up COVAX Doses Despite Domestic Pressure – ACT Accelerator proposes manufacturing task force 23/03/2021 Kerry Cullinan In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New TB Screening Tools Combine X-Rays & AI 23/03/2021 Menaka Rao NEW DELHI – Reversing decades of negative messages, the World Health Organisation is once again endorsing the use of X-rays as a TB screening tool in lower-income countries – this time in conjunction with the use of new artificial intelligence programmes that can read digital x-rays and identify suspected TB cases more accurately. For community-level […] Continue reading -> Norway Gives Up COVAX Doses Despite Domestic Pressure – ACT Accelerator proposes manufacturing task force 23/03/2021 Kerry Cullinan In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Norway Gives Up COVAX Doses Despite Domestic Pressure – ACT Accelerator proposes manufacturing task force 23/03/2021 Kerry Cullinan In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> Posts navigation Older postsNewer posts